Post-pandemic Era-Global Angiopoietin 2 Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
MRAResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Angiopoietin 2 market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Angiopoietin 2 Market by MRAResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Angiopoietin 2 Market?
Amgen Inc.
AnGes MG, Inc.
Boehringer Ingelheim GmbH
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
MedImmune, LLC
Regeneron Pharmaceuticals, Inc.
RXi Pharmaceuticals Corporation
Silence Therapeutics Plc
Synergys Biotherapeutics, Inc.
...
Major Type of Angiopoietin 2 Covered in MRAResearch report
Atu-111
BI-836880
LY-3127804
MEDI-3617
Others
Application Segments Covered in MRAResearch Market
Hospital
Clinic
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Angiopoietin 2 Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Atu-111 -Product Introduction and Major Manufacturers
1.1.2 BI-836880 -Product Introduction and Major Manufacturers
1.1.3 LY-3127804 -Product Introduction and Major Manufacturers
1.1.4 MEDI-3617 -Product Introduction and Major Manufacturers
1.1.5 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Angiopoietin 2 Status and Prospect (2015-2026)
2.1.1 China Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.1.2 China Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Angiopoietin 2 Status and Prospect (2015-2026)
2.2.1 EU Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.2.2 EU Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Angiopoietin 2 Status and Prospect (2015-2026)
2.3.1 USA Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.3.2 USA Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Angiopoietin 2 Status and Prospect (2015-2026)
2.4.1 Japan Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.4.2 Japan Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Angiopoietin 2 Status and Prospect (2015-2026)
2.5.1 India Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.5.2 India Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Angiopoietin 2 Status and Prospect (2015-2026)
2.6.1 Southeast Asia Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Angiopoietin 2 Status and Prospect (2015-2026)
2.7.1 South America Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.7.2 South America Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Angiopoietin 2 Status and Prospect (2015-2026)
2.8.1 Angiopoietin 2 Market Size and Growth Rate (2015-2026)
2.8.2 Angiopoietin 2 Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Angiopoietin 2 Market Assessment by Segment
3.1 Global Angiopoietin 2 Capacity and Growth Rate
3.2 Global Angiopoietin 2 Sales by Type
3.3 Global Angiopoietin 2 Sales Revenue by Type
3.4 Global Angiopoietin 2 Consumption by Application
4 Global Angiopoietin 2 Market Assessment by Regions
4.1 Global Angiopoietin 2 Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Angiopoietin 2 Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Angiopoietin 2 Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Angiopoietin 2 Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Angiopoietin 2 Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Angiopoietin 2 Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Angiopoietin 2 Sales Market Share of Manufacturers (2019-2020)
6.3 Global Angiopoietin 2 Sales Revenue Market Share of Manufacturers (2019-2020)
7 Angiopoietin 2 Competitive Analysis
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Profiles
7.1.2 Amgen Inc. Product Introduction
7.1.3 Amgen Inc. Angiopoietin 2 Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 AnGes MG, Inc.
7.2.1 AnGes MG, Inc. Company Profiles
7.2.2 AnGes MG, Inc. Product Introduction
7.2.3 AnGes MG, Inc. Angiopoietin 2 Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Company Profiles
7.3.2 Boehringer Ingelheim GmbH Product Introduction
7.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Profiles
7.4.2 Eli Lilly and Company Product Introduction
7.4.3 Eli Lilly and Company Angiopoietin 2 Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Profiles
7.5.2 F. Hoffmann-La Roche Ltd. Product Introduction
7.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 MedImmune, LLC
7.6.1 MedImmune, LLC Company Profiles
7.6.2 MedImmune, LLC Product Introduction
7.6.3 MedImmune, LLC Angiopoietin 2 Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Regeneron Pharmaceuticals, Inc.
7.7.1 Regeneron Pharmaceuticals, Inc. Company Profiles
7.7.2 Regeneron Pharmaceuticals, Inc. Product Introduction
7.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 RXi Pharmaceuticals Corporation
7.8.1 RXi Pharmaceuticals Corporation Company Profiles
7.8.2 RXi Pharmaceuticals Corporation Product Introduction
7.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Silence Therapeutics Plc
7.9.1 Silence Therapeutics Plc Company Profiles
7.9.2 Silence Therapeutics Plc Product Introduction
7.9.3 Silence Therapeutics Plc Angiopoietin 2 Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Synergys Biotherapeutics, Inc.
7.10.1 Synergys Biotherapeutics, Inc. Company Profiles
7.10.2 Synergys Biotherapeutics, Inc. Product Introduction
7.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
8 Conclusion
List of Figure
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Angiopoietin 2 Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Angiopoietin 2 Sales (K Unit) by Type (2015-2026)
Figure Global Angiopoietin 2 Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Angiopoietin 2 Sales Market Share (%) by Type (2019 -2020)
Table Global Angiopoietin 2 Sales Value (Million USD) by Type (2015-2026)
Figure Global Angiopoietin 2 Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Angiopoietin 2 Sales Value Market Share (%) by Type (2019-2020)
Table Global Angiopoietin 2 Sales (K Unit) by Application (2015-2026)
Figure China Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table China Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table India Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Angiopoietin 2 Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Angiopoietin 2 Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Angiopoietin 2 Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Angiopoietin 2 Capacity (K Units) and Growth Rate (2015-2026)
Table Global Angiopoietin 2 Sales (Unit) by Type (2015-2026)
Figure Global Angiopoietin 2 Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Angiopoietin 2 Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Angiopoietin 2 Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Angiopoietin 2 Consumption (Unit) by Application (2015-2026)
Figure Global Angiopoietin 2 Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Angiopoietin 2 Production (K Unite) by Regions (2015-2020)
Table Global Angiopoietin 2 CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Angiopoietin 2 Production Share by Regions (2019-2020)
Table Global Angiopoietin 2 Sales (K Unite) by Regions (2015-2020)
Table Global Angiopoietin 2 CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Angiopoietin 2 Sales Share by Regions (2019-2020)
Table Global Angiopoietin 2 Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Angiopoietin 2 CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Angiopoietin 2 Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Angiopoietin 2
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Angiopoietin 2
Figure Cost Structure of Angiopoietin 2 in 2020
Table Global Angiopoietin 2 Capacity Share of Manufacturers (2019-2020)
Figure Global Angiopoietin 2 Capacity Share of Manufacturers (2019-2020)
Table Global Angiopoietin 2 Sales Market Share of Manufacturers (2019-2020)
Figure Global Angiopoietin 2 Sales Market Share of Manufacturers (2019-2020)
Table Global Angiopoietin 2 Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Angiopoietin 2 Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Angiopoietin 2 Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ????Amgen Inc. Profiles
Table ????Amgen Inc. Angiopoietin 2 Product Introduction
Table ????Amgen Inc. Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Amgen Inc. SWOT Analysis
Table ????AnGes MG, Inc. Profiles
Table ????AnGes MG, Inc. Angiopoietin 2 Product Introduction
Table ????AnGes MG, Inc. Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????AnGes MG, Inc. SWOT Analysis
Table ????Boehringer Ingelheim GmbH Profiles
Table ????Boehringer Ingelheim GmbH Angiopoietin 2 Product Introduction
Table ????Boehringer Ingelheim GmbH Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Boehringer Ingelheim GmbH SWOT Analysis
Table ????Eli Lilly and Company Profiles
Table ????Eli Lilly and Company Angiopoietin 2 Product Introduction
Table ????Eli Lilly and Company Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Eli Lilly and Company SWOT Analysis
Table ????F. Hoffmann-La Roche Ltd. Profiles
Table ????F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product Introduction
Table ????F. Hoffmann-La Roche Ltd. Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????F. Hoffmann-La Roche Ltd. SWOT Analysis
Table ????MedImmune, LLC Profiles
Table ????MedImmune, LLC Angiopoietin 2 Product Introduction
Table ????MedImmune, LLC Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????MedImmune, LLC SWOT Analysis
Table ????Regeneron Pharmaceuticals, Inc. Profiles
Table ????Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product Introduction
Table ????Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Regeneron Pharmaceuticals, Inc. SWOT Analysis
Table ????RXi Pharmaceuticals Corporation Profiles
Table ????RXi Pharmaceuticals Corporation Angiopoietin 2 Product Introduction
Table ????RXi Pharmaceuticals Corporation Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????RXi Pharmaceuticals Corporation SWOT Analysis
Table ????Silence Therapeutics Plc Profiles
Table ????Silence Therapeutics Plc Angiopoietin 2 Product Introduction
Table ????Silence Therapeutics Plc Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Silence Therapeutics Plc SWOT Analysis
Table ????Synergys Biotherapeutics, Inc. Profiles
Table ????Synergys Biotherapeutics, Inc. Angiopoietin 2 Product Introduction
Table ????Synergys Biotherapeutics, Inc. Angiopoietin 2 Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Synergys Biotherapeutics, Inc. SWOT Analysis
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices